Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 4Patient Satisfaction 2Urologic Neoplasms 1Urologic Diseases 1Urinary Bladder Diseases 1Rectal Neoplasms 1Patient Participation 1Ileus 1

Interventions

Cystectomy 2tislelizumab 1relatlimab 1enzalutamide 1durvalumab 1Urinary Diversion 1Radiosurgery 1Nivolumab 1Multiparametric Magnetic Resonance Imaging 1Microscopy 1Immunonutrition Diet 1Immune Checkpoint Inhibitors 1Gemcitabine 1Cystoscopy 1Cisplatin 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Urinary Bladder Diseases × Urinary Diversion × Clear all
NCT05241340 2025-10-24

RAD-VACCINE

The Methodist Hospital Research Institute

Phase 2 Active not recruiting
33 enrolled
Genitourinary

Urinary Bladder Diseases, Urinary Bladder Neoplasms, Urologic Diseases, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡